Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML.

Blood
Sewa RijalAndrew H Wei

Abstract

Phosphoinositide signaling regulates diverse cellular functions. Phosphoinositide-3 kinase (PI3K) generates PtdIns(3,4,5)P3 and PtdIns(3,4)P2, leading to the activation of proliferative and anti-apoptotic signaling pathways. Termination of phosphoinositide signaling requires hydrolysis of inositol ring phosphate groups through the actions of PtdIns(3,4,5)P3 3-phosphatase (PTEN), PtdIns(3,4,5)P3 5-phosphatases (eg, SHIP), and PtdIns(3,4)P2 4-phosphatases (eg, INPP4B). The biological relevance of most of these phosphoinositide phosphatases in acute myeloid leukemia (AML) remains poorly understood. Mass spectrometry-based gene expression profiling of 3-, 4- and 5-phosphatases in human AML revealed significant overexpression of INPP4B. Analysis of an expanded panel of 205 AML cases at diagnosis revealed INPP4B overexpression in association with reduced responses to chemotherapy, early relapse, and poor overall survival, independent of other risk factors. Ectopic overexpression of INPP4B conferred leukemic resistance to cytosine arabinoside (ara-C), daunorubicin, and etoposide. Expression of a phosphatase inert variant (INPP4B C842A) failed to abrogate resistance of AML cells to chemotherapy in vitro or in vivo. In contrast, targete...Continue Reading

References

Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·M M GeorgescuH Hanafusa
Mar 8, 2000·American Journal of Hematology·T C LiuS F Lin
Aug 31, 2000·European Journal of Haematology·A AggerholmP Hokland
Jan 24, 2002·Molecular Cell·Diana Murray, Barry Honig
Mar 8, 2003·Proceedings of the National Academy of Sciences of the United States of America·Chunming Ding, Charles R Cantor
Feb 4, 2006·Blood·Frederick R AppelbaumStephen H Petersdorf
Mar 14, 2007·Biochemical and Biophysical Research Communications·Colin T Shearn, F Anderson Norris
Mar 11, 2009·The Biochemical Journal·Lisa M OomsChristina A Mitchell
Oct 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arati V RaoBob Löwenberg
Dec 4, 2010·Proceedings of the National Academy of Sciences of the United States of America·Clare G FedeleChristina A Mitchell
Aug 30, 2011·Nature Medicine·Kolja EppertJohn E Dick
Aug 14, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alan K BurnettDonald Milligan

❮ Previous
Next ❯

Citations

Nov 18, 2015·The FEBS Journal·Andrés Alonso, Rafael Pulido
Sep 29, 2015·Oncogene·S T GuoC C Jiang
Jul 8, 2015·Trends in Molecular Medicine·John F WoolleyLeonardo Salmena
May 2, 2015·Blood·Christian Recher
Oct 27, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ping WangYan Li
Mar 9, 2018·Journal of Cellular and Molecular Medicine·Ying ChenWeiming Zhao
Dec 30, 2016·Molecular and Cellular Biology·Elizabeth A Sierra PotchanantGrzegorz Nalepa
Jan 19, 2018·Journal of Experimental & Clinical Cancer Research : CR·Hongjun JinLing Zhang
Jan 14, 2017·Bioscience Reports·Samuel J RodgersLisa M Ooms
Nov 7, 2019·Oncotarget·Emily Marie MangialardiLeonardo Salmena
Mar 17, 2019·Biological Research·Feng ZhangPingping Zhang
Apr 17, 2020·Frontiers in Oncology·Luca GozzelinoMiriam Martini
Apr 26, 2020·Molecular Biology Reports·Ningni JiangJuan Peng
Mar 31, 2021·Drug Discovery Today·Mehrdad IzadiradZhe-Sheng Chen
May 27, 2021·Nature Communications·Samuel J RodgersChristina A Mitchell
Mar 7, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gang YangJin Gu
Jul 4, 2021·Advances in Biological Regulation·Sabryn A HamilaChristina A Mitchell

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.